Stay updated on Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record appears unchanged, with no visible updates to its study details or other content.SummaryDifference0.0%

- Check13 days agoChange DetectedThe clinical trial record for pembrolizumab combined with chemotherapy for advanced ovarian, primary peritoneal, and fallopian tube cancer is displayed, with details on participation, locations, treatment, and outcome measures.SummaryDifference60%

- Check20 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner was added announcing NIH website transition updates and saying that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2, while the study record page continues to display a 403 error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.